Lung Cancer Trials Ask AI to find trials
RecruitingNot applicableNCT06424327
Official study title

A Registry for People With Lung Cancer

Study summary

Participants will complete questionnaires before surgery, between 2 to 4 weeks after surgery, and 6 months after surgery.

Ask AI to explain this study
Start here

Key things to know

Main goalNot specified

This describes the study’s primary purpose.

What is being studiedPatient-Reported Outcomes Measurement Information System

The study team can explain what participation involves.

Who it may be forEarly-stage or resectable

These are broad labels—not an eligibility decision.

Checked against the public recordLast updated Sep 24, 2026 · Source: ClinicalTrials.gov

Is enrollment open?Recruiting

The study is currently accepting participants.

What kind of study?Not applicable

Observational

Where is it offered?20 U.S. locations

Locations may change over time.

Who runs it?Memorial Sloan Kettering Cancer Center

Study sponsor

01
Study overview

What this study is about

Purpose
Not specified
Study type
Observational
Phase
Not applicable
Sponsor
Memorial Sloan Kettering Cancer Center
Interventions being studied
Other: Patient-Reported Outcomes Measurement Information System
02
Explore related studies

How this study is categorized

These labels come from structured fields and exact terms in the public record.

Disease setting
Early-stage or resectable→
Treatment approach
Surgery→
Study topics
Before surgery (neoadjuvant)→After surgery (adjuvant)→
03
Public criteria

Who may be able to participate

The sponsor separates these requirements into two groups. You do not need to interpret them alone—use them to guide a conversation with the study team.

Requirements people may need to meetInclusion criteria
  • Age ≥18 years
  • Patients suitable for segmentectomy, according to the treating surgeon
  • Clinical Stage I with suspected NSCLC, classified preoperatively based on the AJCC TNM staging manual, 9th edition o Note: Tissue diagnosis of NSCLC is not required before enrollment. A pathologic diagnosis of NSCLC may be confirmed preoperatively with biopsy, intraoperatively with frozen section, or postoperatively on final pathology
Reasons someone may not be able to joinExclusion criteria
  • Actively receiving lung cancer treatment or a history of lung cancer in the previous 5 years
  • History of chemotherapy or radiation therapy for a previous lung cancer
  • Synchronous secondary cancer in the lung or elsewhere in the body at the time of surgery
  • Carcinoid tumors
  • History of other malignancies within the past 3 years, with the exception of non-melanoma skin cancer, superficial bladder cancer, and carcinoma in situ of the cervix
  • Actively receiving treatment for other malignancies
  • Cases of lobectomy in conjunction with segmentectomy from another lobe and ≥2 segmentectomies from different lobes either en bloc or separate will be excluded from the primary analysis.
  • Multi-segmental resection from the same lobe is not a criterion for exclusion.

Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.

04
Study sites

U.S. locations

  • University of Arizona (Data Collection Only)Tucson, Arizona
  • University of California San Diego (Data collection)San Diego, California
  • Rush University Medical Center (Data collection only)Chicago, Illinois
  • Endeavor HealthEvanston, Illinois
  • Massachusetts General Hospital Cancer Center (Data Collection Only)Boston, Massachusetts
  • Brigham and Women's Hospital (Data Collection Only)Boston, Massachusetts
  • University of Michigan (Data Collection Only)Ann Arbor, Michigan
  • Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities)Basking Ridge, New Jersey
  • Memorial Sloan Kettering Monmouth (Limited Protocol Activities)Middletown, New Jersey
  • Memorial Sloan Kettering Bergen (Limited Protocol Activities)Montvale, New Jersey
  • Memorial Sloan Kettering Suffolk - Commack (Limited Protocol Activities)Commack, New York
  • Memorial Sloan Kettering Westchester (Limited Protocol Activities)Harrison, New York

Source and freshness
Processed from ClinicalTrials.gov. Last public update: Sep 24, 2026. Always confirm current availability with the study team.

View original record ↗